Nexina Tablets
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
MFDS item code 200203564 · Notified 2002.09.27
This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastric acid-related disorders (e.g., ulcers, gastritis, and gastroesophageal reflux disease); prevention of Mendelson syndrome
This medication is used for the treatment of gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, gastroesophageal reflux disease, prevention of Mendelson's syndrome before anesthesia, and for ulcers due to surgery and non-steroidal anti-inflammatory drugs (NSAIDs).
○ Adults The usual dose is 2 tablets per dose, taken orally twice daily, in the morning and at bedtime, regardless of meals. 1) Gastric and duodenal ulcers Take 2 tablets per dose twice daily or 4 tablets once daily at bedtime. In particular, a higher healing rate may be achieved in patients with duodenal ulcers by taking 4 tablets per dose twice daily, in the morning and at bedtime. The same dosage applies to concomitant therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks; however, healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, maintenance therapy is 2 tablets once daily at bedtime. 2) Gastroesophageal reflux disease Take 2 tablets per dose twice daily for 8 weeks or 4 tablets once daily at bedtime. For patients with severe gastroesophageal reflux disease, the dose may be increased to 4 tablets per dose 4 times daily. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 2 tablets per dose 3 times daily; the dose may be increased as needed. In severe cases, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions Once oral administration is possible, switch from injection to oral administration and take 2 tablets per dose twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Take 2 tablets as a single dose 2 hours before induction of anesthesia. It is also preferable to take 2 tablets as a single dose on the night before surgery.
This drug should not be administered to patients undergoing dialysis or those with impaired renal function. Additionally, it should not be given to patients with a history of allergic reactions to this drug or its components, patients with acute porphyria, patients who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants or newborns, and patients on potassium-restricted diets. Patients with liver dysfunction or a history of drug allergies, elderly patients, patients with a history of renal impairment, and those taking non-steroidal anti-inflammatory drugs should use this medication with increased caution. This drug may mask symptoms of gastric cancer, so patients over middle age with newly developed or changed digestive symptoms should confirm the absence of malignant disease before using it. Patients with Helicobacter pylori in gastric and duodenal ulcers require eradication therapy. Patients in severe intensive care or those with hypophosphatemia, or patients with swallowing difficulties require special attention. Very rarely, severe allergic reactions such as anaphylactic shock may occur while taking this medication, so if any unusual symptoms arise, treatment should be stopped immediately and appropriate medical attention sought. If adverse reactions appear such as skin rash, urticaria, angioedema, fever, or bronchospasm, use should be discontinued. Abnormalities in blood tests may occur, so if symptoms like fatigue, bleeding, or fever appear, immediate consultation with medical personnel is necessary. Liver dysfunction, arrhythmias, digestive symptoms (nausea, vomiting, constipation, diarrhea, etc.), dizziness, drowsiness, mental confusion, and headaches have also been reported, requiring caution. If no treatment effect is observed without long-term use, it is advisable to switch to another medication, and elderly patients or those with chronic lung disease, diabetes, or immunocompromised conditions should be mindful of the increased risk of pneumonia. Patients experiencing dizziness or sleepiness while taking this medication should avoid driving or operating dangerous machinery. This medication may interact with other drugs, so it is important to inform healthcare providers, especially when used with anticoagulants, certain antibiotics, or anticonvulsants, and take care to adjust dosing intervals as necessary. Pregnant or breastfeeding women are advised not to use this medication, and its safety in children has not been established, so it is better to avoid administration in pediatrics. In cases of overdose, treatment measures such as vomiting or gastric lavage may be necessary, and in severe cases, hemodialysis can be performed to remove it. This medication can reduce gastric acid secretion, potentially promoting bacterial growth in the stomach; therefore, regular monitoring, including eye examinations, is necessary when used for long periods.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is recommended to keep the storage temperature between 1 and 30 degrees Celsius at room temperature to maintain the efficacy of the medication.
Round white film-coated tablets
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride · Tripotassium Bismuth Dicitrate +1 more
Prescription medication · Combination
Hankook Hyutex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.